The abstract lists biosensors as a key direction within nanotechnology for ischemic cardiomyopathy.
First-pass extracted concept
biosensor
Candidate: concept label2 source documents5 linked claims
Live refresh every 5sNext refresh in 5s
Extracted Explainers
What the tool is doing
Evidence Snippets
The key directions in this field contain cardiac tissue engineering, biosensor, targeted drug delivery and molecular imaging.
This paper attempts to give an overview of the sensing approaches... This leads to a comprehensive overview and a reappreciation of the term biosensor.
Supporting Sources
Linked Claims
Biosensors are used in modern medicine, basic research, and consumer point-of-care and wearable devices.
Quoted textsource-backed
Biosensors are an integral part of modern medicine, are used in basic research, and are increasingly used by consumers as point-of-care and wearable devices.
The paper argues that biosensors should include not only devices with a molecular biorecognition element and physico-chemical readout but also sensing of living biological systems using physical and chemical methods and the use of living biological systems for sensing purposes.
Quoted textsource-backed
This leads to a comprehensive overview and a reappreciation of the term biosensor, including not only devices with a molecular biorecognition element and physico-chemical readout but also the sensing of living biological systems using physical and chemical methods, and the use of living biological systems for sensing purposes.
Technological approaches underlying biosensors are rapidly expanding and include spectroscopic sensing, artificial bioreceptors, synthetic biological approaches, whole-cell biosensors, and artificial intelligence.
Quoted textsource-backed
Meanwhile, the underlying technological approaches are rapidly expanding, including spectroscopic sensing, artificial bioreceptors, synthetic biological approaches, whole-cell biosensors, and artificial intelligence.
Diversification of biosensor applications and technologies is blurring the scope and meaning of the term biosensor.
Quoted textsource-backed
With these diversifications in applications as well as technology, the scope and meaning of the term biosensor is blurring.
Key directions in nanotechnology for ischemic cardiomyopathy include cardiac tissue engineering, biosensors, targeted drug delivery, and molecular imaging.